新闻源 财富源

2019年10月18日 星期五

康缘药业(600557)公告正文

江苏康缘药业股份有限公司2004年第三季度报告

公告日期:2004-10-20


                江苏康缘药业股份有限公司2004年第三季度报告

    1重要提示
    1.1本公司董事会及其董事保证本报告所载资料不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性负个别及连带责任。
    1.2公司第三季度财务报告未经审计。
    1.3本公司负责人肖伟董事长、主管会计工作负责人穆敏财务总监及会计机构负责人王吉洪部长声明:保证季度报告中财务会计报告真实、完整。
    2公司基本情况
    2.1公司基本信息
股票简称        康缘药业      变更前简称(如有)
股票代码        600557
                            董事会秘书                      证券事务代表
姓名                       程凡
联系地址                   江苏省连云港市新浦区海昌南路58
                           号
电话                       0518-5521990
传真                       0518-5521983
电子信箱                   chf@kanion.com
    2.2财务资料
    2.2.1主要会计数据及财务指标
                                                             币种:人民币
                                  本报告期末                  上年度期末
总资产(元)                    832,103,285.07
股东权益(不含少数股东        393,605,769.77              370,447,169.94
权益)(元)
每股净资产(元)                         2.522                       4.035
调整后的每股净资产                     2.471                       3.936
(元)
                                      报告期            年初至报告期期末
                                  (7-9月)                  (1-9月)
经营活动产生的现金流            3,511,030.69               39,262,972.20
量净额(元)
每股收益(元)                           0.055                       0.204
净资产收益率(%)                       2.17                        8.10
扣除非经常性损益后的                    2.08                        8.21
净资产收益率(%)

                                                        本报告期末比上年
                                                        度期末增减(%)
总资产(元)                                                          6.89
股东权益(不含少数股东                                              6.25
权益)(元)
每股净资产(元)                                                    -37.50
调整后的每股净资产                                                -37.22
(元)
                                                        本报告期比上年同
                                                            期增减(%)
经营活动产生的现金流
量净额(元)
每股收益(元)                                                      -54.17
净资产收益率(%)                                       下降1.01个百分点
扣除非经常性损益后的                                   下降了1.1个百分点
净资产收益率(%)
非经常性损益项目                                                    金额
减项
营业外收入                                                     20,327.39
补贴收入                                                       20,000.00
技术改造项目财政贴息                                          630,000.00
所得税影响                                                   -221,208.04
增项
营业外支出                                                    907,319.88
流动资产盘亏                                                  418,496.10
所得税影响                                                   -437,519.27
合计                                                         -439,177.36
    2.2.2利润表
    利润表
                                              单位:元币种:人民币未经审计
                                                本期数(7-9)月
项目              编号
                                       合并                       母公司
一、主营业务收入             175,962,788.12                91,487,591.79
减:主营业务成本              91,238,975.01                18,996,501.69
主营业务税金及                 1,591,958.34                 1,437,818.08
附加
二、主营业务利润              83,131,854.77                71,053,272.02
加:其他业务利润                 953,783.62                   645,454.05
减:营业费用                  52,046,544.58                43,880,620.80
管理费用                      16,830,834.54                14,108,776.98
财务费用                       2,550,098.21                 1,947,659.10
三、营业利润                  12,658,161.06                11,761,669.19
加:投资收益                           0.00                   641,881.83
补贴收入                               0.00                         0.00
营业外收入                         1,009.88                         0.21
减:营业外支出                   222,936.20                   186,675.44
四、利润总额                  12,436,234.74                12,216,875.79
减:所得税                     3,739,259.36                 3,682,038.72
减:少数股东收益                 162,138.31                         0.00
五、净利润                     8,534,837.07                 8,534,837.07

                                            上年同期数(7-9)月
项目
                                       合并                       母公司
一、主营业务收入             142,503,539.43                72,538,884.68
减:主营业务成本              72,250,693.13                13,178,278.80
主营业务税金及                 1,279,329.04                 1,221,473.86
附加
二、主营业务利润              68,973,517.26                58,139,132.02
加:其他业务利润                 585,816.01                   147,357.55
减:营业费用                  36,296,633.41                31,408,707.27
管理费用                      14,594,660.85                 9,664,586.33
财务费用                       2,099,543.41                   605,086.29
三、营业利润                  16,568,495.60                16,608,109.68
加:投资收益                      57,600.00                    15,168.17
补贴收入                               0.00                         0.00
营业外收入                       329,946.67                   308,372.67
减:营业外支出                   135,726.39                   107,445.77
四、利润总额                  16,820,315.88                16,824,204.75
减:所得税                     5,575,127.22                 5,565,990.08
减:少数股东收益                 -59,004.70                         0.00
五、净利润                    11,304,193.36                11,258,214.67
    利润表
                                              单位:元币种:人民币未经审计
                                           年初至报告期数(1-9)月
项目               编号
                                       合并                       母公司
一、主营业务收入             437,435,014.74               267,050,092.33
减:主营业务成本             191,440,494.90                50,984,787.11
主营业务税金及                 4,797,239.19                 4,348,143.37
附加
二、主营业务利润             241,197,280.65               211,717,161.85
加:其他业务利润               3,124,912.05                 2,342,667.61
减:营业费用                 138,769,878.53               121,262,128.85
管理费用                      49,621,029.41                41,170,743.67
财务费用                       7,519,030.41                 5,630,490.74
三、营业利润                  48,412,254.35                45,996,466.20
加:投资收益                     103,019.45                 1,492,342.32
补贴收入                          20,000.00                    20,000.00
营业外收入                        27,976.16                    20,327.39
减:营业外支出                 1,013,696.44                   907,319.88
四、利润总额                  47,549,553.52                46,621,816.03
减:所得税                    15,329,677.50                14,755,017.04
减:少数股东收益                 353,077.03                         0.00
五、净利润                    31,866,798.99                31,866,798.99

                                            上年同期数(1-9)月
项目
                                       合并                       母公司
一、主营业务收入             293,502,847.61               211,267,748.98
减:主营业务成本             106,755,012.64                40,676,127.52
主营业务税金及                 3,575,043.21                 3,376,003.18
附加
二、主营业务利润             183,172,791.76               167,215,618.28
加:其他业务利润               1,316,698.93                   878,330.55
减:营业费用                 104,899,958.07                97,379,926.49
管理费用                      42,040,395.81                35,027,856.19
财务费用                       2,130,736.88                   446,094.77
三、营业利润                  35,418,399.93                35,240,071.38
加:投资收益                      62,202.09                    63,741.80
补贴收入                               0.00                         0.00
营业外收入                       337,766.67                   308,372.67
减:营业外支出                   458,124.56                   417,573.50
四、利润总额                  35,360,244.13                35,194,612.35
减:所得税                    11,799,553.79                11,628,224.58
减:少数股东收益                 -51,676.12                         0.00
五、净利润                    23,612,366.46                23,566,387.77
    2.3前十名流通股股东持股表
                                                                单位:股
    报告期末股东总数(户)                                     19,331户
                             前十名流通股股东持股情况
                                期末持有流通股             种类(A、B、H
股东名称(全称)
                                        的数量                 股或其它)
上海市慈善基金会                     1,912,668                       A股
融通新蓝筹证券投资基金               1,094,520                       A股
上海证券有限责任公司                   806,960                       A股
中信证券股份有限公司                   792,362                       A股
上海上实资产经营有限公司               290,683                       A股
朱苏海                                 103,827                       A股
纪广祥                                 100,000                       A股
陈层                                   100,000                       A股
王录华                                  95,450                       A股
李倩                                    91,570                       A股
    3管理层讨论与分析
    3.1公司报告期内经营活动总体状况的简要分析
    公司主营业务为中成药制剂、保健品制造、销售。报告期内,公司继续保持持续稳定的增长。年初至报告期,公司实现主营业务收入43743.50万元、净利润3186.68万元,较去年同期分别增长49.04%、34.96%。其中母公司实现主营业务收入26705.01万元、净利润3186.68万元,较去年同期分别增长26.40%、35.22%。
    报告期内,公司获得"银杏叶颗粒"新药证书一个;募集资金项目"年产12亿粒桂枝茯苓胶囊高科技产业化示范工程"项目顺利通过国家发改委验收;部分新药产品桂枝茯苓胶囊、天舒胶囊、抗骨增生胶囊、腰痹痛胶囊、都梁软胶囊、银翘解毒软胶囊、十滴水软胶囊和复方丹参颗粒等共8个新药产品和一个仿制新药六位地黄软胶囊列入《国家基本医疗保险和工伤保险药品目录》。
    3.1.1占主营收入或主营业务利润总额10%以上的主营行业或产品情况
    √适用□不适用
                                              单位:元币种:人民币未经审计
分行业                            主营业务收入              主营业务成本
医药工业                        294,869,001.22             61,750,439.73
医药商业                        147,075,955.66            134,199,997.31
其中:关联交易                    4,509,942.14              4,509,942.14
分产品
胶囊                            263,118,600.09             43,963,071.31
口服液                           17,035,579.25              7,381,522.12
冲剂                              6,121,868.53              4,416,509.12
片、丸剂                          8,592,953.35              5,989,337.18

分行业                                                         毛利率(%)
医药工业                                                           79.06
医药商业                                                            8.75
其中:关联交易
分产品
胶囊                                                               83.29
口服液                                                             56.67
冲剂                                                               27.86
片、丸剂                                                           30.30
    3.1.2公司经营的季节性或周期性特征
    □适用√不适用
    3.1.3报告期利润构成情况(主营业务利润、其他业务利润、期间费用、投资收益、补贴收入与营业外收支净额在利润总额中所占比例与前一报告期相比的重大变动及原因的说明)
    □适用√不适用
    3.1.4主营业务及其结构与前一报告期相比发生重大变化的情况及原因说明
    □适用√不适用
    3.1.5主营业务盈利能力(毛利率)与前一报告期相比发生重大变化的情况及其原因说明
    □适用√不适用
    3.2重大事项及其影响和解决方案的分析说明
    √适用□不适用
    1、公司原第一大股东连云港恒瑞集团有限公司将其持有的43,149,400股国有法人股转让给连云港康贝尔医疗器械有限公司、连云港金典科技开发有限公司和连云港康居房地产开发有限公司。2004年7月23日,上述股权转让行为在中国证券登记结算有限责任公司上海分公司办理完成了股权过户手续。至此,康贝尔公司和金典公司分别持有公司14,825,700股,占总股本的9.50%,成为公司并列第二大股东,康居公司持有公司13,498,000股,占总股本的8.65%,成为公司第四大股东。连云港天使投资发展有限公司持有公司17,215,730股,占总股本的11.03%,成为公司第一大股东。上述转让行为的详细内容和公告情况已在公司半年度报告中进行了详尽披露。
    2、公司股东连云港市天使大药房有限公司更名为连云港天使投资发展有限公司,公告情况已在公司半年度报告中进行了详尽披露。
    3.3会计政策、会计估计、合并范围变化以及重大会计差错的情况及原因说明
    □适用√不适用
    3.4经审计且被出具"非标意见"情况下董事会和监事会出具的相关说明
    □适用√不适用
    3.5预测年初至下一报告期期末的累计净利润可能为亏损或者与上年同期相比发生大幅度变动的警示及原因说明
    □适用√不适用
    3.6公司对已披露的年度经营计划或预算的滚动调整情况
    □适用√不适用
    江苏康缘药业股份有限公司
    肖伟
     2004年10月18日
    4附录:
    资产负债表
                                              单位:元币种:人民币未经审计
                                                期末数
项目               编号
                                    合并                          母公司
流动资产:
货币资金                  115,733,918.59                  104,575,967.34
短期投资
应收票据                   28,588,853.05                   16,517,793.19
应收股利                      115,200.00                      115,200.00
应收利息
应收账款                  180,558,594.81                  123,356,631.07
其他应收款                 50,311,813.60                   52,585,813.00
预付账款                   29,843,358.58                   28,879,815.10
应收补贴款
存货                       42,317,174.50                   20,630,971.25
待摊费用                      519,150.01                      519,150.01
一年内到期的长期
债权投资
其他流动资产
流动资产合计              447,988,063.14                  347,181,340.96
长期投资:
长期股权投资               10,713,486.11                   28,052,522.06
长期债权投资
长期投资合计               10,713,486.11                   28,052,522.06
固定资产:
固定资产原价              317,397,630.50                  296,879,150.17
减:累计折旧               39,627,361.54                   35,536,361.34
固定资产净值              277,770,268.96                  261,342,788.83
减;固定资产减值准          1,654,046.52                    1,452,446.55

固定资产净额              276,116,222.44                  259,890,342.28
工程物资
在建工程                   45,467,904.60                   29,460,329.20
固定资产清理
固定资产合计              321,584,127.04                  289,350,671.48
无形资产及其他资
产:
无形资产                   47,652,391.31                   23,515,176.19
长期待摊费用                4,165,217.47                    3,978,153.07
其他长期资产
无形资产及其他资           51,817,608.78                   27,493,329.26
产合计
递延税项:
递延税款借项
资产总计                  832,103,285.07                  692,077,863.76
流动负债:
短期借款                  229,540,000.00                  198,540,000.00
应付票据                    7,258,559.99                    7,258,559.99
应付账款                   87,839,378.40                   23,736,521.11
预收账款                    1,196,908.89
应付工资                    4,088,283.75                    3,211,617.62
应付福利费                  2,000,313.85                      885,479.43
应付股利                    3,174,822.00                    3,174,822.00
应交税金                   20,116,138.26                   18,612,080.01
其他应交款                  1,684,990.81                    1,661,257.95
其他应付款                 42,262,481.28                   27,291,755.88
预提费用                      452,925.00
预计负债
一年内到期的长期
负债
其他流动负债
流动负债合计              399,614,802.23                  284,372,093.99
长期负债:
长期借款                   20,000,000.00
应付债券
长期应付款
专项应付款                 14,100,000.00                   14,100,000.00
其他长期负债
长期负债合计               34,100,000.00                   14,100,000.00
递延税项:
递延税款贷项
负债合计                  433,714,802.23                  298,472,093.99
少数股东权益:              4,782,713.07
所有者权益(或股东
权益)
实收资本(或股本)        156,060,000.00                  156,060,000.00
减;已归还投资
实收资本(或股本)        156,060,000.00                  156,060,000.00
净额
资本公积                  165,303,446.24                  165,303,446.24
盈余公积                   15,419,104.90                   15,419,104.90
其中:法定公益金           -7,635,547.55                   -7,635,547.55
未分配利润                 56,823,218.63                   56,823,218.63
所有者权益(或股东        393,605,769.77                  393,605,769.77
权益)合计
负债和所有者权益          832,103,285.07                  692,077,863.76
(或股东权益)总计

                                                      期初数
项目
                                    合并                          母公司
流动资产:
货币资金                  158,517,882.36                  141,473,212.47
短期投资
应收票据                   15,739,774.96                   13,587,058.65
应收股利                      115,200.00                      115,200.00
应收利息
应收账款                  163,786,376.68                  114,804,588.20
其他应收款                 33,448,068.02                   32,009,428.41
预付账款                   20,329,445.37                   19,523,588.00
应收补贴款
存货                       37,229,875.70                   17,045,147.95
待摊费用                      413,666.67                      413,666.67
一年内到期的长期
债权投资
其他流动资产
流动资产合计              429,580,289.76                  338,971,890.35
长期投资:
长期股权投资               11,113,486.11                   27,810,640.23
长期债权投资
长期投资合计               11,113,486.11                   27,810,640.23
固定资产:
固定资产原价              313,788,847.87                  293,409,647.54
减:累计折旧               34,966,086.32                   31,273,330.14
固定资产净值              278,822,761.55                  262,136,317.40
减;固定资产减值准          1,654,046.52                    1,452,446.55

固定资产净额             277,168,715.032                   60,683,870.85
工程物资
在建工程                   40,031,831.82                   27,297,637.42
固定资产清理
固定资产合计              317,200,546.85                  287,981,508.27
无形资产及其他资
产:
无形资产                   48,860,771.25                   24,597,376.03
长期待摊费用                4,571,431.74                    4,374,590.65
其他长期资产
无形资产及其他资           53,432,202.99                   28,971,966.68
产合计
递延税项:
递延税款借项
资产总计                  811,326,525.71                  683,736,005.53
流动负债:
短期借款                  249,540,000.00                  198,540,000.00
应付票据                   12,009,536.10                   12,009,536.10
应付账款                   78,429,222.66                   21,446,414.16
预收账款                      678,125.76
应付工资                    4,088,283.75                    3,211,617.62
应付福利费                  1,472,757.42                      454,031.23
应付股利                    3,174,822.00                    3,174,822.00
应交税金                   17,135,862.10                   15,963,767.00
其他应交款                  1,619,990.50                    1,600,011.18
其他应付款                 38,502,059.44                   27,593,987.52
预提费用                    1,230,941.70                      917,469.20
预计负债
一年内到期的长期
负债
其他流动负债
流动负债合计              407,881,601.43                  284,911,656.01
长期负债:
长期借款
应付债券
长期应付款
专项应付款                 14,080,000.00                   14,080,000.00
其他长期负债
长期负债合计               14,080,000.00                   14,080,000.00
递延税项:
递延税款贷项
负债合计                  421,961,601.43                  298,991,656.01
少数股东权益:              4,620,574.76
所有者权益(或股东
权益)
实收资本(或股本)        156,060,000.00                  156,060,000.00
减;已归还投资
实收资本(或股本)        156,060,000.00                  156,060,000.00
净额
资本公积                  164,976,863.06                  164,976,863.06
盈余公积                   15,419,104.90                   15,419,104.90
其中:法定公益金          -7,635,547.55-                    7,635,547.55
未分配利润                 48,288,381.56                   48,288,381.56
所有者权益(或股东        384,744,349.52                  384,744,349.52
权益)合计
负债和所有者权益          811,326,525.71                  683,736,005.53
(或股东权益)总计
    现金流量表
                                              单位:元币种:人民币未经审计
项目                                编号                            合并
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金                              410,262,476.04
收到的税费返还
收到的其他与经营活动有关的现                               15,425,827.32

现金流入小计                                              425,688,303.36
购买商品、接受劳务支付的现金                              158,704,379.14
支付给职工以及为职工支付的现                               22,984,288.48

支付的各项税费                                             52,498,069.58
支付的其他与经营活动有关的现                              152,238,593.96

现金流出小计                                              386,425,331.16
经营活动产生的现金流量净额                                 39,262,972.20
二、投资活动产生的现金流量:
收回投资所收到的现金
取得投资收益所收到的现金
处置固定资产、无形资产和其他长                                106,070.06
期资产所收回的现金净额
收到的其他与投资活动有关的现

现金流入小计                                                  106,070.06
购建固定资产、无形资产和其他长                            129,009,139.08
期资产所支付的现金
投资所支付的现金                                            4,567,300.00
支付的其他与投资活动有关的现

现金流出小计                                              133,576,439.08
投资活动产生的现金流量净额                               -133,470,369.02
三、筹资活动产生的现金流量:
吸收投资所收到的现金                                         -232,379.52
借款所收到的现金                                          218,783,425.11
收到的其他与筹资活动有关的现                                  850,000.00

现金流入小计                                              219,401,045.59
偿还债务所支付的现金                                      207,783,425.11
分配股利、利润偿付利息所支付的                             14,136,505.32
现金
支付的其他与筹资活动有关的现                                5,373,585.45

现金流出小计                                              227,293,515.88
筹资活动产生的现金流量净额                                 -7,892,470.29
四、汇率变动对现金的影响
五、现金及现金等价物净增加额                             -102,099,867.11
补充资料
1、将净利润调节为经营活动现金
流量:
净利润                                                     31,866,798.99
加:少数股东收益                                              353,077.03
计提的资产减值准备                                            577,930.29
固定资产折旧                                               10,221,356.26
无形资产摊销                                                3,624,482.82
长期待摊费用摊销                                            2,162,521.12
待摊费用减少(减:增加)                                    1,031,849.99
预提费用增加(减:减少)                                    1,002,925.00
处置固定资产、无形资产和其他长                                 15,327.18
期资产的损失(减;收益)
固定资产报废损失                                             -150,000.00
财务费用                                                    7,511,958.28
投资损失(减:收益)                                         -103,019.45
递延税款贷项(减:借项)
存货的减少(减:增加)                                     -7,443,004.85
经营性应收项目的减少(减:增加)                             -53,350,422.57
经营性应付项目的增加(减:减少)                              41,941,192.11
其他
经营活动产生的现金流量净额                                 39,262,972.20
2、不涉及现金收支的投资和筹资
活动:
债务转为资本
一年内到期的可转换公司债券
融资租入固定资产
3、现金及现金等价物净增加情况:
现金的期末余额                                            115,733,918.59
减:现金的期初余额                                        217,833,785.70
加:现金等价物的期末余额
减:现金等价物的期初余额
现金及现金等价物净增加额                                 -102,099,867.11

项目                                                              母公司
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金                              255,398,762.54
收到的税费返还
收到的其他与经营活动有关的现                               14,213,355.31

现金流入小计                                              269,612,117.85
购买商品、接受劳务支付的现金                               39,343,857.49
支付给职工以及为职工支付的现                               15,083,140.79

支付的各项税费                                             46,667,501.72
支付的其他与经营活动有关的现                              133,416,785.23

现金流出小计                                              234,511,285.23
经营活动产生的现金流量净额                                 35,100,832.62
二、投资活动产生的现金流量:
收回投资所收到的现金
取得投资收益所收到的现金
处置固定资产、无形资产和其他长                                106,070.06
期资产所收回的现金净额
收到的其他与投资活动有关的现

现金流入小计                                                  106,070.06
购建固定资产、无形资产和其他长                            120,772,464.68
期资产所支付的现金
投资所支付的现金                                            4,567,300.00
支付的其他与投资活动有关的现

现金流出小计                                              125,339,764.68
投资活动产生的现金流量净额                               -125,233,694.62
三、筹资活动产生的现金流量:
吸收投资所收到的现金                                         -232,379.52
借款所收到的现金                                          173,540,000.00
收到的其他与筹资活动有关的现                                  850,000.00

现金流入小计                                              174,157,620.48
偿还债务所支付的现金                                      162,540,000.00
分配股利、利润偿付利息所支付的                             12,648,112.23
现金
支付的其他与筹资活动有关的现                                5,373,585.45

现金流出小计                                              180,561,697.68
筹资活动产生的现金流量净额                                 -6,404,077.20
四、汇率变动对现金的影响
五、现金及现金等价物净增加额                              -96,536,939.20
补充资料
1、将净利润调节为经营活动现金
流量:
净利润                                                     31,866,798.99
加:少数股东收益
计提的资产减值准备                                            486,870.99
固定资产折旧                                                9,030,774.49
无形资产摊销                                                3,246,599.52
长期待摊费用摊销                                            1,189,313.24
待摊费用减少(减:增加)                                    1,031,849.99
预提费用增加(减:减少)                                      550,000.00
处置固定资产、无形资产和其他长                                 15,327.18
期资产的损失(减;收益)
固定资产报废损失                                             -150,000.00
财务费用                                                    5,630,490.74
投资损失(减:收益)                                       -1,492,342.32
递延税款贷项(减:借项)
存货的减少(减:增加)                                     -5,760,421.76
经营性应收项目的减少(减:增加)                             -44,042,530.21
经营性应付项目的增加(减:减少)                              33,498,101.77
其他
经营活动产生的现金流量净额                                 35,100,832.62
2、不涉及现金收支的投资和筹资
活动:
债务转为资本
一年内到期的可转换公司债券
融资租入固定资产
3、现金及现金等价物净增加情况:
现金的期末余额                                            104,575,967.34
减:现金的期初余额                                        201,112,906.54
加:现金等价物的期末余额
减:现金等价物的期初余额
现金及现金等价物净增加额                                  -96,536,939.20